The latest price target for Madrigal Pharmaceuticals (NASDAQ:MDGL) was reported by Piper Sandler on December 19, 2025. The analyst firm set a price target for $900.00 expecting MDGL to rise to within ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback